Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

New targeted drugs for metastatic renal cell carcinoma

Share :

ECCO 15 - ESMO 34

20 - 24 Sep 2009
Published: 25 Sep 2009
Views: 12071
Rating:
Save
Dr Joaquim Bellmunt - Section Chief, Solid Tumor Oncology, Hospital del Mar, Barcelona, Spain
Expert interview with Dr Joaquim Bellmunt MD PhD conducted by Prof Gordon McVie

Related Videos

Cancer Journeys: Research from India
Ms. Soumita Ghose - Tata Medical Center, Kolkata
Cancer Journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )
7 Sep 2024
Depression in cancer
Ms. Bidisha Samanta - Rocket Health, Kolkata, India
Depression in cancer ( Ms. Bidisha Samanta - Rocket Health, Kolkata, India )
7 Sep 2024
Managing 'Fear of Recurrence' of cancer patients
Ms. Bincy Mathew - Manipal Hospitals. Bangalore, India
Managing 'Fear of Recurrence' of cancer patients ( Ms. Bincy Mathew - Manipal Hospitals. Bangalore, India )
7 Sep 2024
Psychological issues in familial cancer
Dr. Arnab Mukherjee - Tata Medical Center, Kolkata, India
Psychological issues in familial cancer ( Dr. Arnab Mukherjee - Tata Medical Center, Kolkata, India )
7 Sep 2024
Pancreatic, hepatic and biliary malignancies
Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA
Pancreatic, hepatic and biliary malignancies ( Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA )
12 Jul 2024
Administering systemic chemotherapy improves survival for patients with...
Dr Giacomo Bregni - Francis Crick Institute, London, England
Administering systemic chemotherapy improves survival for patients with resectable CRCLM ( Dr Giacomo Bregni - Francis Crick Institute, London, England )
9 Jul 2024
Whole body-MRI and fluorine 18 fluorodeoxyglucose PET/CT shows promising...
Dr Claudio Cerchione - IRCCS, Meldola, Italy
Whole body-MRI and fluorine 18 fluorodeoxyglucose PET/CT shows promising diagnostic accuracy in multiple myeloma patients ( Dr Claudio Cerchione - IRCCS, Meldola, Italy )
25 Jun 2024
Trial argues strongly for the development of 1st-line biomarker selected...
Prof Jennifer Knox - University of Toronto, Toronto, Canada
Trial argues strongly for the development of 1st-line biomarker selected strategies in pancreatic ductal adenocarcinoma ( Prof Jennifer Knox - University of Toronto, Toronto, Canada )
4 Jun 2024
Durvalumab plus bevacizumab, added to TACE, shows benefit for unresectable...
Dr Riccardo Lencioni - University of Pisa, Pisa, Italy
Durvalumab plus bevacizumab, added to TACE, shows benefit for unresectable hepatocellular carcinoma ( Dr Riccardo Lencioni - University of Pisa, Pisa, Italy )
25 Jan 2024

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation